Skip to content

Cerba Research

Active
Public limited companyfounded 1983active for 42 yearsIndustriepark-Zwijnaarde 3, 9052 Gent, BelgiumKBO/BCE: BE 0425.663.615
Risk analysisFollow ReportCompare
Cerba ResearchActiveChecked score 53/100
Risk analysis ReportCompare

Directors

Directors
4 directors, 1 in day-to-day management, no change since 2025

Board 4

David Christiaan Peters
Director · appointed in the act of 27-06-2024
Current
Maria Fotiu
Director · since 14-03-2025 · term until the 2028 general meeting · listed in the 2025 annual accounts, filed on 29-06-2026
Current
Julien Samson
Director · since 12-09-2025 · listed in the 2025 annual accounts, filed on 29-06-2026
Current
Nathalie Lomon
Director · since 12-09-2025 · listed in the 2025 annual accounts, filed on 29-06-2026
Current

Day-to-day management 1

Maria Fotiu
Managing director · appointed in the act of 31-10-2025
Current

Statutory auditor 1

GRANT THORNTON BEDRIJFSREVISOREN - REVISEURS D'ENTREPRISES
Statutory auditor · since 09-03-2026 · permanent representative: Elie Janssens · listed in the 2025 annual accounts, filed on 29-06-2026
Current
Office holders in the KBO →

Owners and capital

Shareholders

1 owner

Chain of control

  1. Chrome TopcoFR consolidates
  2. Cerba Research

Owners 1

Capital transactions

Shareholders according to the deeds
After the capital increase act of 20-12-2022 ↗
  • Cerba HealthCare International
Capital over time
  1. 20-12-2022 Capital increase of €50,000,000 · to €94,796,000.04 · 4,633,920 new shares · in kind
  2. 04-12-2020 Capital increase of €23,000,000 · to €65,882,488.12 · 1,448,869 new shares
  3. 04-12-2020 Capital reduction of €21,086,488.08 · to €44,796,000.04 · “aanzuivering van geleden (overgedragen) verliezen”
  4. 04-03-2020 Capital stated in the deed · €42,882,488.12 · 2,701,352 shares
  5. 25-01-2017 Capital increase of €23,000,000 · to €63,436,460.33 · 979,422 new shares
  6. 25-01-2017 Capital reduction of €20,553,972.21 · to €42,882,488.12 · aanzulvering verliezen (16.353.972,21) en vorming reserve (4.200.000,00)
  7. 22-11-2012 Capital increase of €3,000,000 · to €31,436,460.33 · 127,751 new shares
  8. 22-11-2012 Capital increase of €9,000,000 · to €40,436,460.33 · 383,252 new shares
Show 2 older capital entries
  1. 12-04-2011 Capital increase of €60,000,000 · to €60,062,000 · 1,209,677 new shares · in kind
  2. 12-04-2011 Capital reduction of €31,625,539.67 · to €28,436,460.33 · to absorb losses

Mandate history

25 people, 5 in office
Show
  • Board
  • Day-to-day management
  • Statutory auditor
  • began earlier
  • end not dated
Mandates per person, with start and end dates
Name Functions and periods
David Christiaan Peters
  • Director, appointed in the act of 27-06-2024, still in office
Maria Fotiu
  • Director, from 14-03-2025 to date
  • Managing director, appointed in the act of 31-10-2025, still in office
Julien Samson
  • Director, from 12-09-2025 to date
Nathalie Lomon
  • Director, from 12-09-2025 to date
GRANT THORNTON BEDRIJFSREVISOREN - REVISEURS D'ENTREPRISES
  • Statutory auditor, appointed in the act of 02-06-2026, still in office
BV PwC Bedrijfsrevisoren
  • Statutory auditor, appointed in the act of 22-11-2016, until 02-06-2026
Paul Navarre
  • Chair of the board, appointed in the act of 27-06-2024, ended, last mentioned on 31-10-2025
  • Director, appointed in the act of 27-06-2024, until 12-09-2025
Emmanuel Ligner
  • Director, appointed in the act of 27-06-2024, until 13-03-2025
  • Managing director, appointed in the act of 27-06-2024, until 13-03-2025
  • Director, until 13-03-2025
Nuala Murphy
  • Director, appointed in the act of 27-06-2024, until 01-04-2024
  • Managing director, appointed in the act of 27-06-2024, until 01-04-2024
Philippe Buhl
  • Director, appointed in the act of 17-08-2023, until 01-04-2024
Mario PAPILLON
  • Director, appointed in the act of 23-11-2021, until 30-11-2023
  • Managing director, appointed in the act of 23-11-2021, until 30-11-2023
Jérôme THILL
  • Director, from before 07-06-2013 to 09-11-2023
  • Managing director, appointed in the act of 19-03-2015, until 01-07-2021
  • Chair of the board, appointed in the act of 17-08-2023, ended, last mentioned on 17-08-2023
Catherine RONDOT-COURBOILLET
  • Chair of the board, from before 07-06-2013, ended, last mentioned on 21-10-2022
  • Director, from before 07-06-2013 to 17-08-2023
  • Director and chair of the board, until 17-08-2023
Peter OPSOMER
  • Statutory auditor, appointed in the act of 11-07-2013, until 02-09-2016
Johan Albrecht
  • Director, appointed in the act of 07-11-2011, ended, last mentioned on 11-07-2013
  • Managing director, appointed in the act of 07-11-2011, until 12-01-2015
BVCV Grant Thornton, Lippens & Rabay
  • Statutory auditor, appointed in the act of 31-08-2010, until 31-05-2013
Catherine Courboillet
  • Managing director, appointed in the act of 28-09-2011, until 11-10-2011
BVCV Grant Thornton, Lippens & Rabaey
  • Statutory auditor, appointed in the act of 09-07-2007, until 20-04-2010
Rudi Mariën
  • Managing director, from before 31-05-2007 to 15-09-2009
Aguja BVBA
  • Director, from before 31-05-2007 to 05-10-2007
Argon CVA
  • Director, until 05-10-2007
L.K.C. NV
  • Director, until 05-10-2007
Stefan Mariën
  • Director, from before 31-05-2007 to 05-10-2007
Argon Comm VA
  • Managing director, from before 31-05-2007, last mentioned in 2007
CKL NV
  • Director, from before 31-05-2007, no longer listed in the 2025 annual accounts

Next steps

See this company's board, registered office and name on a given date.Company as of a date See what became of the directors' other companies.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file

We would like to set cookies. That happens only with your consent. What we measure